top of page

Lars Lannfelt, inventor of the approved (in the U.S. and elsewhere) Alzheimer's medicine Leqembi, describes how the drug works and shares his understanding of Alzheimer's disease

  • blonca9
  • Sep 21, 2024
  • 1 min read

Professor Lannfelt recounts the history of researching amyloid beta and explains why he thinks it is vital to target amyloid beta protofibrils to have an impact on the disease. Plus, the future of treating Alzheimer's earlier and getting more of the medicine into the brain, both of which BioArctic is currently working on.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page